346 related articles for article (PubMed ID: 26477383)
1. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
Xuan J; Chen S; Ning B; Tolleson WH; Guo L
Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.
Chen S; Wu Q; Li X; Li D; Mei N; Ning B; Puig M; Ren Z; Tolleson WH; Guo L
J Environ Sci Health C Toxicol Carcinog; 2021; 39(1):68-86. PubMed ID: 33576714
[TBL] [Abstract][Full Text] [Related]
3. The role of hepatic cytochrome P450s in the cytotoxicity of dronedarone.
Chen S; Wu Q; Ning B; Bryant M; Guo L
Arch Toxicol; 2018 Jun; 92(6):1969-1981. PubMed ID: 29616291
[TBL] [Abstract][Full Text] [Related]
4. The role of hepatic cytochrome P450s in the cytotoxicity of sertraline.
Chen S; Wu Q; Li X; Li D; Fan M; Ren Z; Bryant M; Mei N; Ning B; Guo L
Arch Toxicol; 2020 Jul; 94(7):2401-2411. PubMed ID: 32372212
[TBL] [Abstract][Full Text] [Related]
5. The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib.
Chen S; Li X; Li Y; He X; Bryant M; Qin X; Li F; Seo JE; Guo X; Mei N; Guo L
Toxicol Sci; 2023 Dec; 197(1):69-78. PubMed ID: 37788138
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
7. Study of the roles of cytochrome P450 (CYPs) in the metabolism and cytotoxicity of perhexiline.
Ren Z; Chen S; Qin X; Li F; Guo L
Arch Toxicol; 2022 Dec; 96(12):3219-3231. PubMed ID: 36083301
[TBL] [Abstract][Full Text] [Related]
8. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
Marill J; Cresteil T; Lanotte M; Chabot GG
Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM; Schwab M
Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
[TBL] [Abstract][Full Text] [Related]
11. The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity.
Wu Q; Ning B; Xuan J; Ren Z; Guo L; Bryant MS
Toxicol Lett; 2016 Jun; 253():55-62. PubMed ID: 27113703
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids.
Marill J; Capron CC; Idres N; Chabot GG
Biochem Pharmacol; 2002 Mar; 63(5):933-43. PubMed ID: 11911845
[TBL] [Abstract][Full Text] [Related]
13. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans.
Gustafsson F; Foster AJ; Sarda S; Bridgland-Taylor MH; Kenna JG
Toxicol Sci; 2014 Jan; 137(1):189-211. PubMed ID: 24085192
[TBL] [Abstract][Full Text] [Related]
14. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
Sarikaya D; Bilgen C; Kamataki T; Topcu Z
Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
[TBL] [Abstract][Full Text] [Related]
16. Acetaminophen-Induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver.
Bao Y; Wang P; Shao X; Zhu J; Xiao J; Shi J; Zhang L; Zhu HJ; Ma X; Manautou JE; Zhong XB
Drug Metab Dispos; 2020 May; 48(5):326-336. PubMed ID: 32094214
[TBL] [Abstract][Full Text] [Related]
17. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.
Teschke R; Danan G
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810530
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver.
Furukawa M; Nishimura M; Ogino D; Chiba R; Ikai I; Ueda N; Naito S; Kuribayashi S; Moustafa MA; Uchida T; Sawada H; Kamataki T; Funae Y; Fukumoto M
Cancer Sci; 2004 Jun; 95(6):520-9. PubMed ID: 15182434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
